Open original FDA record ↗Recall record
- FDA identifier
- Z-0585-2026
- Company in FDA record
- Remel, Inc
- FDA classification date
- Nov 21, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Products may contain contamination, which may result in a darker or brown media color.
Source facts
- Action
- On November 13, 2025, firm began notifying customers via Urgent Medical Device Recall letters. Customers were advised to review results and destroy any remaining inventory of affected lots. Affected product should not be used for any clinical laboratory testing. Customers should complete the acknowledgement form provided by the firm indicating number of units destroyed in order to receive replacement/credit.
- Initiated
- 2025-11-12
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution in the states of AK, CA, FL, GA, IA, IL, IN, LA, MA, MD, ME, MI, MN, NE, NY, OH, OK, PA, RI, SD, TN, VA, WA, WI and the countries of Brazil, Canada, China, Cyprus, Finland, Great Britain, Ireland, Moldova, Norway, Singapore.
- Recall number
- Z-0585-2026
- Recall status
- Open, Classified
- CDRH record ID
- 217343
- FDA classified
- 2025-11-21
- Recall event number
- 97967